1. Home
  2. RVMD vs PSN Comparison

RVMD vs PSN Comparison

Compare RVMD & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • PSN
  • Stock Information
  • Founded
  • RVMD 2014
  • PSN 1944
  • Country
  • RVMD United States
  • PSN United States
  • Employees
  • RVMD N/A
  • PSN N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • PSN EDP Services
  • Sector
  • RVMD Health Care
  • PSN Technology
  • Exchange
  • RVMD Nasdaq
  • PSN Nasdaq
  • Market Cap
  • RVMD 7.5B
  • PSN 8.6B
  • IPO Year
  • RVMD 2020
  • PSN 2019
  • Fundamental
  • Price
  • RVMD $47.66
  • PSN $87.68
  • Analyst Decision
  • RVMD Strong Buy
  • PSN Strong Buy
  • Analyst Count
  • RVMD 15
  • PSN 12
  • Target Price
  • RVMD $74.47
  • PSN $90.09
  • AVG Volume (30 Days)
  • RVMD 2.3M
  • PSN 1.1M
  • Earning Date
  • RVMD 11-05-2025
  • PSN 11-05-2025
  • Dividend Yield
  • RVMD N/A
  • PSN N/A
  • EPS Growth
  • RVMD N/A
  • PSN 23.64
  • EPS
  • RVMD N/A
  • PSN 2.23
  • Revenue
  • RVMD N/A
  • PSN $6,683,116,000.00
  • Revenue This Year
  • RVMD N/A
  • PSN N/A
  • Revenue Next Year
  • RVMD $454.11
  • PSN $5.98
  • P/E Ratio
  • RVMD N/A
  • PSN $40.09
  • Revenue Growth
  • RVMD N/A
  • PSN 9.22
  • 52 Week Low
  • RVMD $29.17
  • PSN $54.56
  • 52 Week High
  • RVMD $62.40
  • PSN $114.68
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 65.02
  • PSN 65.83
  • Support Level
  • RVMD $45.80
  • PSN $86.67
  • Resistance Level
  • RVMD $49.50
  • PSN $89.27
  • Average True Range (ATR)
  • RVMD 1.54
  • PSN 2.06
  • MACD
  • RVMD 0.04
  • PSN 0.61
  • Stochastic Oscillator
  • RVMD 72.95
  • PSN 82.07

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: